University of California, Davis scientists are teaming up with renowned genome editing researchers on a $70m donor-funded initiative that aims in part to block methane emissions from cattle by using CRISPR tools on microbes in the cows’ gut.
US endomicrobial-based products producer, Ascus Bioscience, said the US$46m it has secured in a Series B funding round leaves it well positioned to continue expanding its sales and servicing teams, and to advance new and existing products in its product...